BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38216080)

  • 1. Long-term Survival After Lung Cancer Resection in the National Lung Screening Trial.
    Potter AL; Senthil P; Keshwani A; McCleery S; Haridas C; Kumar A; Mathey-Andrews C; Martin LW; Yang CJ
    Ann Thorac Surg; 2024 Apr; 117(4):734-742. PubMed ID: 38216080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
    Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
    Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303.
    Mimae T; Saji H; Nakamura H; Okumura N; Tsuchida M; Sonobe M; Miyazaki T; Aokage K; Nakao M; Haruki T; Okada M; Suzuki K; Chida M
    Ann Surg Oncol; 2021 Nov; 28(12):7219-7227. PubMed ID: 33900499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy.
    Mimae T; Miyata Y; Yoshimura K; Tsutani Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M
    Jpn J Clin Oncol; 2021 Oct; 51(10):1561-1569. PubMed ID: 34331062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial.
    Hattori A; Suzuki K; Takamochi K; Wakabayashi M; Sekino Y; Tsutani Y; Nakajima R; Aokage K; Saji H; Tsuboi M; Okada M; Asamura H; Nakamura K; Fukuda H; Watanabe SI; ;
    Lancet Respir Med; 2024 Feb; 12(2):105-116. PubMed ID: 38184010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of lobectomy, segmentectomy, and wedge resection for stage I non-small cell lung cancer.
    Zhang Y; Sun Y; Wang R; Ye T; Zhang Y; Chen H
    J Surg Oncol; 2015 Mar; 111(3):334-40. PubMed ID: 25322915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
    Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
    Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.
    Hou B; Deng XF; Zhou D; Liu QX; Dai JG
    Ther Adv Respir Dis; 2016 Oct; 10(5):435-43. PubMed ID: 27585599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublobectomy versus lobectomy for stage IA (T1a) non-small-cell lung cancer: a meta-analysis study.
    Liu Y; Huang C; Liu H; Chen Y; Li S
    World J Surg Oncol; 2014 May; 12():138. PubMed ID: 24886396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence After Complete Resection for Non-Small Cell Lung Cancer in the National Lung Screening Trial.
    Potter AL; Costantino CL; Suliman RA; Haridas CS; Senthil P; Kumar A; Mayne NR; Panda N; Martin LW; Yang CJ
    Ann Thorac Surg; 2023 Oct; 116(4):684-692. PubMed ID: 37356517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Saji H; Okada M; Tsuboi M; Nakajima R; Suzuki K; Aokage K; Aoki T; Okami J; Yoshino I; Ito H; Okumura N; Yamaguchi M; Ikeda N; Wakabayashi M; Nakamura K; Fukuda H; Nakamura S; Mitsudomi T; Watanabe SI; Asamura H;
    Lancet; 2022 Apr; 399(10335):1607-1617. PubMed ID: 35461558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer: An Analysis from the National Cancer Data Base.
    Khullar OV; Liu Y; Gillespie T; Higgins KA; Ramalingam S; Lipscomb J; Fernandez FG
    J Thorac Oncol; 2015 Nov; 10(11):1625-33. PubMed ID: 26352534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar resection is equivalent to lobectomy for T1a non-small cell lung cancer in the elderly: a Surveillance, Epidemiology, and End Results database analysis.
    Razi SS; John MM; Sainathan S; Stavropoulos C
    J Surg Res; 2016 Feb; 200(2):683-9. PubMed ID: 26490227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data.
    Kates M; Swanson S; Wisnivesky JP
    Chest; 2011 Mar; 139(3):491-496. PubMed ID: 20576736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal Disease.
    Mynard N; Nasar A; Rahouma M; Lee B; Harrison S; Chow O; Villena-Vargas J; Altorki N; Port J
    Ann Thorac Surg; 2022 Sep; 114(3):959-967. PubMed ID: 35181271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy.
    Tsutani Y; Kagimoto A; Handa Y; Mimae T; Miyata Y; Okada M
    Jpn J Clin Oncol; 2019 Dec; 49(12):1134-1142. PubMed ID: 31602468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison Between Wedge Resection and Lobectomy/Segmentectomy for Early-Stage Non-small Cell Lung Cancer: A Bayesian Meta-analysis and Systematic Review.
    Shi Y; Wu S; Ma S; Lyu Y; Xu H; Deng L; Chen X
    Ann Surg Oncol; 2022 Mar; 29(3):1868-1879. PubMed ID: 34613537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.